Preliminary research has suggested that deep-transcranial magnetic stimulation (TMS) may be an effective noninvasive therapy to treat negative symptoms and cognitive deficits in patients with schizophrenia -- important but often inadequately controlled aspects of the disease.
So Yechiel Levkovitz, MD, director of the Emotion-Cognition Research Center, Shalvata Mental Health Care Center in Hod-Hasharon, Israel, and colleagues, conducted the first double-blind, randomized sham-controlled study to examine the feasibility and efficacy of deep-TMS as add-on treatment in 30 patients.
One month after treatment, daily H1 deep-TMS significantly reduced negative symptoms and cognitive deficits in the TMS group but not the control group, the researchers found.
A study in the Journal of Psychopharmacology examined deep-transcranial magnetic stimulation (TMS) as a non-invasive treatment option negative symptoms and cognitive deficits in patients with schizophrenia.
Enjoying our content?
Thanks for visiting Psychiatry Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Psychiatry Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Evidence-Based Guidance
- Conference Coverage
- Unique Psychiatry Case Studies
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.